Mirati Therapeutics Inc
NASDAQ:MRTX
Mirati Therapeutics Inc
Net Issuance of Common Stock
Mirati Therapeutics Inc
Net Issuance of Common Stock Peer Comparison
Competitive Net Issuance of Common Stock Analysis
Latest Figures & CAGR of Competitors
Company | Net Issuance of Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Mirati Therapeutics Inc
NASDAQ:MRTX
|
Net Issuance of Common Stock
$346.2m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
9%
|
CAGR 10-Years
30%
|
|
Abbvie Inc
NYSE:ABBV
|
Net Issuance of Common Stock
-$1.1B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
37%
|
CAGR 10-Years
-18%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Net Issuance of Common Stock
-$719m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
22%
|
CAGR 10-Years
-2%
|
|
Amgen Inc
NASDAQ:AMGN
|
Net Issuance of Common Stock
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Net Issuance of Common Stock
-$288.7m
|
CAGR 3-Years
15%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Net Issuance of Common Stock
-$473.2m
|
CAGR 3-Years
51%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Mirati Therapeutics Inc's Net Issuance of Common Stock?
Net Issuance of Common Stock
346.2m
USD
Based on the financial report for Sep 30, 2023, Mirati Therapeutics Inc's Net Issuance of Common Stock amounts to 346.2m USD.
What is Mirati Therapeutics Inc's Net Issuance of Common Stock growth rate?
Net Issuance of Common Stock CAGR 10Y
30%
Over the last year, the Net Issuance of Common Stock growth was -46%. The average annual Net Issuance of Common Stock growth rates for Mirati Therapeutics Inc have been -2% over the past three years , 9% over the past five years , and 30% over the past ten years .